Aditxt Inc. (NASDAQ: ADTX), a social innovation platform focused on accelerating health innovations, announced that it will execute a 1-for-27 reverse stock split of its common stock, effective at the opening of trading on the Nasdaq Capital Market on May 18, 2026. The reverse split is designed to bring the company into compliance with Nasdaq’s minimum bid price requirement, a key condition for continued listing on the exchange.
As a result of the reverse split, the number of outstanding common shares will be reduced from approximately 13.8 million to about 510,123. The stock will continue to trade under the symbol ADTX. This corporate action is a strategic move to address the company's stock price, which had fallen below the $1.00 minimum bid price threshold required by Nasdaq. By consolidating shares, the company aims to increase the per-share trading price, thereby regaining compliance and avoiding potential delisting.
The reverse stock split underscores Aditxt's commitment to maintaining its listing on a major exchange, which is crucial for investor confidence and access to capital markets. The company's ability to remain on Nasdaq provides liquidity and visibility, supporting its ongoing operations and growth initiatives.
Aditxt operates as a social innovation platform that accelerates promising health innovations through a collaborative ecosystem involving research institutions, industry partners, and shareholders. The company's model focuses on democratizing innovation and addressing significant societal challenges in healthcare. Aditxt currently runs four programs targeting autoimmunity, cancer and early disease detection, infectious diseases, and women's health.
The reverse split is a common mechanism for companies to adjust their stock price and meet exchange requirements. However, it does not change the underlying value of the company or the proportional ownership of shareholders. Shareholders will receive one share for every 27 shares they previously held, and fractional shares will be rounded up to the nearest whole share.
For more information, the full press release is available at https://ibn.fm/S1uMK. Investors can also find the latest news and updates regarding ADTX in the company’s newsroom at https://ibn.fm/ADTX.
This reverse stock split represents a pivotal step for Aditxt as it seeks to stabilize its stock price and continue its mission of making promising health innovations possible. The company's focus on critical areas like autoimmunity and infectious diseases highlights its potential impact on public health, making its continued listing on Nasdaq important for stakeholders.
